CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 2,551 shares at $3.92 ($10,000)
- 4 Open-market buy GENERAL COUNSEL AND SECRETARY bought 1,000 shares at $4.88 ($4,880)
- 4 Open-market buy Director bought 7,000 shares at $5.00 ($35,000)
- 4 Open-market buy CFO, TREASURER bought 1,000 shares at $4.42 ($4,420)
- 4 Exercise or conversion PRESIDENT AND CEO acquired 2,000 shares (option exercise)
- 4 Open-market buy PRESIDENT AND CEO bought 3,000 shares at $8.02 ($24,060)
- 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 1,050 shares at $7.91 ($8,306)
- 4 Open-market buy CHIEF MEDICAL OFFICER bought 900 shares at $7.49 ($6,737)
- 4 Open-market buy Director bought 6,667 shares at $6.75 ($45,002)
- 4 Open-market buy Director bought 6,000 shares at $6.40 ($38,400)
- 4 Exercise or conversion PRESIDENT AND CEO acquired 2,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 322,691 shares (grant or award)
Page 7 of 9 · 166 filings